⌘K
Loading ticker…
Rigel Pharmaceuticals Inc. (New) · Healthcare · Pharmaceutical Products
As of 2026-06-26, Rigel Pharmaceuticals Inc. (New) (RIGL) has a 3-month relative strength percentile of 89 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.6%, relative volume 2.48×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 89, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RIGL is held by 6 ETFs as of Mar 2026. Top owner: XBI at 0.26% weight, $19M notional. Top 3 carry $46M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| XBIState Street SPDR S&P Biotech ETF | 0.26% | $19M |
| VTIVanguard Total Stock Market ETF | 0.00% | $15M |
| IWMiShares Russell 2000 ETF | 0.02% | $12M |
| VXFVanguard Extended Market ETF | 0.01% | $6M |
| IWOiShares Russell 2000 Growth ETF | 0.03% | $4M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $598K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RIGL Jan avg: 0.03% median: -4.64% win: 50% σ: 23.32% n: 4 2022-04-12 → 2026-05-29 | RIGL Feb avg: 7.04% median: 3.08% win: 50% σ: 16.35% n: 4 2022-04-12 → 2026-05-29 | RIGL Mar avg: -14.84% median: -17.28% win: 0% σ: 9.29% n: 4 2022-04-12 → 2026-05-29 | RIGL Apr avg: -9.40% median: -14.39% win: 40% σ: 16.59% n: 5 2022-04-12 → 2026-05-29 | RIGL May avg: -0.53% median: -1.84% win: 40% σ: 17.27% n: 5 2022-04-12 → 2026-05-29 | RIGL Jun avg: -15.95% median: -11.89% win: 0% σ: 15.44% n: 4 2022-04-12 → 2026-05-29 (current) | RIGL Jul avg: 13.36% median: 9.71% win: 100% σ: 10.68% n: 4 2022-04-12 → 2026-05-29 | RIGL Aug avg: 28.36% median: 23.18% win: 75% σ: 42.13% n: 4 2022-04-12 → 2026-05-29 | RIGL Sep avg: -7.21% median: -11.08% win: 25% σ: 20.45% n: 4 2022-04-12 → 2026-05-29 | RIGL Oct avg: -16.95% median: -20.51% win: 25% σ: 21.07% n: 4 2022-04-12 → 2026-05-29 | RIGL Nov avg: 48.96% median: 50.55% win: 75% σ: 45.74% n: 4 2022-04-12 → 2026-05-29 | RIGL Dec avg: 24.07% median: 6.01% win: 50% σ: 71.63% n: 4 2022-04-12 → 2026-05-29 |